Given our previous discussion on the association of WDHD1 with the cell cycle, we hypothesize that targeting WDHD1 could serve a dual purpose in anticancer therapy, disrupting cancer cell division while restoring cancer immune surveillance. This evidence concerns the gene WDHD1 and cancer.